VanEck Pharmaceutical ETF PPH
Set alert
119.33 USD +2.41 +2.06%
At close · Oct 30
119.94 +0.61 +0.51%
After hours · Oct 30, 6:49 PM ET
118.97 Day range 120.86
92.35 52-week range 119.33
- YTD
- +15.66%
- 1 year
- +29.21%
- Open
- 119.73
- Prev close
- 116.92
- Mkt cap
- 1.07B
- Vol
- 1.28M
- Avg vol
- 306.18K
- EPS
- 4.37
- P/E
- 27.28
- Div yield
- 0.00%
More statistics
- Low
- 118.97
- High
- 120.86
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 112.51
- 200-d avg
- 107.85
3M chart
Events in this range
- Oct 1, 2026Dividend: 0.36
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.28
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 112.51
- 200-day average
- 107.85
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
- Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
- PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)
- Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
- Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
- What's Going On With Merck Stock Tuesday?
- Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes
- Merck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug Discovery
- Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
- Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.